Literature DB >> 27265786

Association of expression levels of pluripotency/stem cell markers with the differentiation outcome of Wharton's jelly mesenchymal stem cells into insulin producing cells.

Dina H Kassem1, Mohamed M Kamal1, Abd El-Latif G El-Kholy2, Hala O El-Mesallamy3.   

Abstract

Recently, there has been much attention towards generation of insulin producing cells (IPCs) from stem cells, especially from Wharton's jelly mesenchymal stem cells (WJ-MSCs). However, generation of mature IPCs remains a challenge. Assessment of generation of IPCs was usually done by examining β-cell markers, however, assessment of pluripotency/stem cell markers drew less attention. Therefore, the purpose of this study was to investigate the levels of pluripotency/stem cell markers during differentiation of WJ-MSCs into IPCs and the association of these levels with differentiation outcomes. WJ-MSCs were isolated, characterized then induced to differentiate into IPCs using three different protocols namely A, B and C. Differentiated IPCs were assessed by the expression of pluripotency/stem cell markers, together with β-cell markers using qRT-PCR, and functionally by measuring glucose stimulated insulin secretion. Differentiated cells from protocol A showed lowest expression of pluripotency/stem cell markers and relatively best GSIS. However, protocol B showed concomitant expression of pluripotency/stem cell and β-cell markers with relatively less insulin secretion as compared to protocol A. Protocol C failed to generate glucose-responsive IPCs. In conclusion, sustained expression of pluripotency/stem cell markers could be associated with the incomplete differentiation of WJ-MSCs into IPCs. A novel finding for which further investigations are warranted.
Copyright © 2016 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; Insulin producing cells; Mesenchymal stem cells; Pluripotency/stem cell markers; Wharton's jelly

Mesh:

Substances:

Year:  2016        PMID: 27265786     DOI: 10.1016/j.biochi.2016.05.019

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  3 in total

1.  Proteomic Profiling of the First Human Dental Pulp Mesenchymal Stem/Stromal Cells from Carbonic Anhydrase II Deficiency Osteopetrosis Patients.

Authors:  Zikra Alkhayal; Zakia Shinwari; Ameera Gaafar; Ayodele Alaiya
Journal:  Int J Mol Sci       Date:  2020-12-31       Impact factor: 5.923

Review 2.  Therapeutic Potential of Wharton's Jelly Mesenchymal Stem Cells for Diabetes: Achievements and Challenges.

Authors:  Mohamed M Kamal; Dina H Kassem
Journal:  Front Cell Dev Biol       Date:  2020-01-29

3.  Therapeutic efficacy of umbilical cord-derived stem cells for diabetes mellitus: a meta-analysis study.

Authors:  Dina H Kassem; Mohamed M Kamal
Journal:  Stem Cell Res Ther       Date:  2020-11-16       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.